Occult macular dystrophy: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{SI}} | |||
{{Infobox medical condition | |||
| name = Occult macular dystrophy | |||
| image = [[File:AmslerGrid.svg|alt=An Amsler grid, used to detect visual disturbances]] | |||
| caption = An [[Amsler grid]], used to detect visual disturbances | |||
| synonyms = OMD | |||
| pronounce = | |||
| specialty = [[Ophthalmology]] | |||
| symptoms = [[Visual acuity]] loss, [[metamorphopsia]] | |||
| onset = Typically in [[adulthood]] | |||
| duration = [[Chronic (medicine)|Chronic]] | |||
| causes = [[Genetic disorder]] | |||
| risks = Family history | |||
| diagnosis = [[Electroretinography]], [[Optical coherence tomography]] | |||
| differential = [[Age-related macular degeneration]], [[Stargardt disease]] | |||
| treatment = No known effective treatment | |||
| medication = | |||
| prognosis = Progressive vision loss | |||
| frequency = Rare | |||
}} | |||
{{Short description|A rare genetic eye disorder affecting the macula}} | {{Short description|A rare genetic eye disorder affecting the macula}} | ||
'''Occult macular dystrophy''' (OMD) is a rare [[genetic disorder]] that affects the [[macula]], the central part of the [[retina]] responsible for sharp, detailed vision. Unlike other forms of macular dystrophy, OMD is characterized by normal appearance of the retina upon examination, despite significant visual impairment. This condition is often challenging to diagnose due to its "occult" nature, meaning the retinal changes are not visible through standard clinical examination. | '''Occult macular dystrophy''' (OMD) is a rare [[genetic disorder]] that affects the [[macula]], the central part of the [[retina]] responsible for sharp, detailed vision. Unlike other forms of macular dystrophy, OMD is characterized by normal appearance of the retina upon examination, despite significant visual impairment. This condition is often challenging to diagnose due to its "occult" nature, meaning the retinal changes are not visible through standard clinical examination. | ||
==Pathophysiology== | ==Pathophysiology== | ||
OMD is primarily caused by mutations in the [[RP1L1]] gene, which plays a crucial role in the function of photoreceptor cells in the retina. These mutations lead to dysfunction of the macular photoreceptors, resulting in progressive loss of central vision. The peripheral vision typically remains unaffected, distinguishing OMD from other retinal dystrophies. | OMD is primarily caused by mutations in the [[RP1L1]] gene, which plays a crucial role in the function of photoreceptor cells in the retina. These mutations lead to dysfunction of the macular photoreceptors, resulting in progressive loss of central vision. The peripheral vision typically remains unaffected, distinguishing OMD from other retinal dystrophies. | ||
==Symptoms== | ==Symptoms== | ||
Patients with OMD often experience a gradual decline in central vision, which can manifest as difficulty reading, recognizing faces, or performing tasks that require fine visual detail. Despite these symptoms, the retina appears normal upon examination with an [[ophthalmoscope]]. | Patients with OMD often experience a gradual decline in central vision, which can manifest as difficulty reading, recognizing faces, or performing tasks that require fine visual detail. Despite these symptoms, the retina appears normal upon examination with an [[ophthalmoscope]]. | ||
==Diagnosis== | ==Diagnosis== | ||
The diagnosis of OMD is challenging due to the lack of visible retinal abnormalities. Advanced diagnostic tools such as [[electroretinography]] (ERG) and [[optical coherence tomography]] (OCT) are essential for detecting the subtle functional and structural changes in the retina. ERG can reveal a selective reduction in macular function, while OCT may show thinning of the macular region. | The diagnosis of OMD is challenging due to the lack of visible retinal abnormalities. Advanced diagnostic tools such as [[electroretinography]] (ERG) and [[optical coherence tomography]] (OCT) are essential for detecting the subtle functional and structural changes in the retina. ERG can reveal a selective reduction in macular function, while OCT may show thinning of the macular region. | ||
[[File:AmslerGridOMD.png|Amsler grid showing distortion typical in OMD|thumb|left]] | [[File:AmslerGridOMD.png|Amsler grid showing distortion typical in OMD|thumb|left]] | ||
==Management== | ==Management== | ||
Currently, there is no cure for OMD, and management focuses on supportive care and visual rehabilitation. Patients may benefit from low vision aids and adaptive technologies to assist with daily activities. Regular monitoring by an [[ophthalmologist]] is recommended to assess the progression of the disease. | Currently, there is no cure for OMD, and management focuses on supportive care and visual rehabilitation. Patients may benefit from low vision aids and adaptive technologies to assist with daily activities. Regular monitoring by an [[ophthalmologist]] is recommended to assess the progression of the disease. | ||
==Prognosis== | ==Prognosis== | ||
The progression of OMD varies among individuals. Some patients may experience a slow decline in vision, while others may have a more rapid progression. The condition does not typically lead to complete blindness, as peripheral vision is preserved. | The progression of OMD varies among individuals. Some patients may experience a slow decline in vision, while others may have a more rapid progression. The condition does not typically lead to complete blindness, as peripheral vision is preserved. | ||
==Research== | ==Research== | ||
Ongoing research aims to better understand the genetic basis of OMD and to develop potential therapies. Gene therapy and other novel treatments are being explored as possible interventions to slow or halt the progression of the disease. | Ongoing research aims to better understand the genetic basis of OMD and to develop potential therapies. Gene therapy and other novel treatments are being explored as possible interventions to slow or halt the progression of the disease. | ||
[[File:OMD_traffic_lights.jpg|Traffic lights as seen by a person with OMD|thumb|left]] | |||
[[File:OMD_traffic_lights.jpg|Traffic lights as seen by a person with OMD|thumb| | ==See also== | ||
== | |||
* [[Macular degeneration]] | * [[Macular degeneration]] | ||
* [[Retinitis pigmentosa]] | * [[Retinitis pigmentosa]] | ||
* [[Stargardt disease]] | * [[Stargardt disease]] | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Eye diseases]] | [[Category:Eye diseases]] | ||
[[Category:Retinal disorders]] | [[Category:Retinal disorders]] | ||
Latest revision as of 04:40, 6 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Occult macular dystrophy | |
|---|---|
| An Amsler grid, used to detect visual disturbances | |
| Synonyms | OMD |
| Pronounce | |
| Specialty | Ophthalmology |
| Symptoms | Visual acuity loss, metamorphopsia |
| Complications | N/A |
| Onset | Typically in adulthood |
| Duration | Chronic |
| Types | N/A |
| Causes | Genetic disorder |
| Risks | Family history |
| Diagnosis | Electroretinography, Optical coherence tomography |
| Differential diagnosis | Age-related macular degeneration, Stargardt disease |
| Prevention | N/A |
| Treatment | No known effective treatment |
| Medication | |
| Prognosis | Progressive vision loss |
| Frequency | Rare |
| Deaths | N/A |
A rare genetic eye disorder affecting the macula
Occult macular dystrophy (OMD) is a rare genetic disorder that affects the macula, the central part of the retina responsible for sharp, detailed vision. Unlike other forms of macular dystrophy, OMD is characterized by normal appearance of the retina upon examination, despite significant visual impairment. This condition is often challenging to diagnose due to its "occult" nature, meaning the retinal changes are not visible through standard clinical examination.
Pathophysiology[edit]
OMD is primarily caused by mutations in the RP1L1 gene, which plays a crucial role in the function of photoreceptor cells in the retina. These mutations lead to dysfunction of the macular photoreceptors, resulting in progressive loss of central vision. The peripheral vision typically remains unaffected, distinguishing OMD from other retinal dystrophies.
Symptoms[edit]
Patients with OMD often experience a gradual decline in central vision, which can manifest as difficulty reading, recognizing faces, or performing tasks that require fine visual detail. Despite these symptoms, the retina appears normal upon examination with an ophthalmoscope.
Diagnosis[edit]
The diagnosis of OMD is challenging due to the lack of visible retinal abnormalities. Advanced diagnostic tools such as electroretinography (ERG) and optical coherence tomography (OCT) are essential for detecting the subtle functional and structural changes in the retina. ERG can reveal a selective reduction in macular function, while OCT may show thinning of the macular region.
Management[edit]
Currently, there is no cure for OMD, and management focuses on supportive care and visual rehabilitation. Patients may benefit from low vision aids and adaptive technologies to assist with daily activities. Regular monitoring by an ophthalmologist is recommended to assess the progression of the disease.
Prognosis[edit]
The progression of OMD varies among individuals. Some patients may experience a slow decline in vision, while others may have a more rapid progression. The condition does not typically lead to complete blindness, as peripheral vision is preserved.
Research[edit]
Ongoing research aims to better understand the genetic basis of OMD and to develop potential therapies. Gene therapy and other novel treatments are being explored as possible interventions to slow or halt the progression of the disease.
